ALL CHARLESTON COUNTY COUNTY SCHOOLS OPERATING NORMALLY ALL SCHOOLS NORMAL 10:50 PM

MUSC Hollings pushes to transform South Carolina cancer care

Gloved researcher hand holding a research vial with a modern medical research building in the background

Charleston’s MUSC Hollings Cancer Center announced this week that it is moving one step closer to transforming cancer care across South Carolina, building on its status as the state’s only National Cancer Institute-designated cancer center and its recent recognition as the top-ranked hospital in South Carolina for cancer care. The Hollings program has spent 2026 […]

Second-hand smoke reached 2.7 billion in 2023

An estimated 2.71 billion people worldwide, including 767 million children under age 15, were exposed to second-hand smoke in 2023, and that exposure contributed to about 1.66 million deaths, according to a Global Burden of Disease Study 2023 analysis published in The Lancet Public Health on September 7, 2026. According to the analysis, second-hand smoke […]

FDA withdraws Krazati Erbitux colorectal approval

The Food and Drug Administration has withdrawn the accelerated approval of Krazati (adagrasib) in combination with Erbitux (cetuximab) for adults with KRAS G12C-mutated locally advanced or metastatic colorectal cancer who have previously been treated with a fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy regimen. The withdrawal took effect September 1, 2026, according to the FDA’s list of […]

Abbott TactiFlex Duo ablation catheter approved

The Food and Drug Administration approved Abbott’s TactiFlex Duo Ablation Catheter, Sensor Enabled, a device that combines pulsed-field ablation and radiofrequency energy in a single catheter to treat complex atrial fibrillation, according to a company announcement dated September 8, 2026. Atrial fibrillation, or AFib, is an irregular heart rhythm that increases the risk of stroke […]

FDA approves Etcamah for ESR1 breast cancer

The Food and Drug Administration on September 4, 2026 granted accelerated approval to Etcamah (camizestrant) in combination with a CDK4/6 inhibitor for adults with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer whose tumors develop an ESR1 mutation during aromatase-inhibitor and CDK4/6-inhibitor therapy, based on an FDA-authorized test. According to the FDA drug-approval notice, this […]

Kofinas garlic olive oil recalled by FDA

LMSI LLC, doing business as Kofinas Olive Oil, is voluntarily recalling its Garlic Mediterranean Infused Extra Virgin Olive Oil because the product contains a garlic essential oil that is not approved for culinary use, according to the recall notice posted by the Food and Drug Administration. The recalled product was bottled in glass bottles in […]

FDA approves RASONQUE for pancreatic cancer

The Food and Drug Administration approved RASONQUE (daraxonrasib), the first targeted therapy in a new class of RAS inhibitors, for adults with metastatic pancreatic adenocarcinoma who have already received at least one line of systemic therapy or who are not candidates for multiagent systemic therapy. The approval was granted to Revolution Medicines, Inc. on August […]

HHS names four permanent senior FDA leaders

The Department of Health and Human Services on September 8, 2026, named four permanent senior leaders at the Food and Drug Administration, filling the top posts at the drug, biologics, and tobacco centers and creating a new deputy commissioner role focused on technology and artificial intelligence. Michael Davis, M.D., Ph.D., moves from acting director to […]

MUSC performs state’s 1st pediatric robotic surgery

MUSC Health performs state's first pediatric single-port robotic surgery

MUSC Health in Charleston recently performed South Carolina’s first pediatric single-port robotic surgery on August 24, 2026, offering new hope to a young patient with a rare bladder condition. The procedure was led by Chad Crigger, M.D., MPH, a reconstructive pediatric urologist, marking a significant advancement in local pediatric surgical options. The patient, Evan, was […]

Daily Nuts May Lower High Blood Pressure Risk

Daily Nuts May Lower High Blood Pressure Risk

New research indicates that consuming approximately a handful of nuts daily could be linked to a reduced risk of developing high blood pressure. A systematic review and meta-analysis, published on August 4 in the British Journal of Nutrition, analyzed eight prospective studies and found that each additional 1-ounce (28-gram) serving of nuts consumed per day […]